SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-22-002541
Filing Date
2022-01-28
Accepted
2022-01-28 16:00:24
Documents
1
Period of Report
2022-01-28

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 447617
  Complete submission text file 0001493152-22-002541.txt   448798
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: DEF 14A | Act: 34 | File No.: 001-37492 | Film No.: 22568672
SIC: 2834 Pharmaceutical Preparations